ATLAS / Macro Radar / Reporting / ABOS

Acumen Pharmaceuticals, Inc. (ABOS) reporting calendar

Acumen Pharmaceuticals, Inc. files periodic reports with the SEC as ABOS on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001628280-26-034204
10-K31 Dec 202526 Mar 202685 days0001628280-26-021413
10-Q30 Sep 202512 Nov 202543 days0001576885-25-000104
10-Q30 Jun 202512 Aug 202543 days0001576885-25-000093
10-Q31 Mar 202513 May 202543 days0001576885-25-000065
10-K31 Dec 202427 Mar 202586 days0001576885-25-000049
10-Q30 Sep 202412 Nov 202443 days0001576885-24-000098
10-Q30 Jun 202413 Aug 202444 days0001576885-24-000092
10-Q31 Mar 202414 May 202444 days0001576885-24-000064
10-K31 Dec 202326 Mar 202486 days0001576885-24-000047
10-Q30 Sep 202313 Nov 202344 days0001576885-23-000062
10-Q30 Jun 20238 Aug 202339 days0001576885-23-000050
10-Q31 Mar 20239 May 202339 days0001576885-23-000025
10-K31 Dec 202227 Mar 202386 days0001576885-23-000017
10-Q30 Sep 202214 Nov 202245 days0001193125-22-284583
10-Q30 Jun 202215 Aug 202246 days0001193125-22-221297
10-Q31 Mar 202216 May 202246 days0001193125-22-151851
10-K31 Dec 202128 Mar 202287 days0001193125-22-086775
10-Q30 Sep 202115 Nov 202146 days0001193125-21-329068
10-Q30 Jun 202116 Aug 202147 days0001193125-21-247879

Source: SEC EDGAR company submissions for CIK 0001576885. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.